快而精医药(QGEN)

49.5475 0.5775 1.1793%

今开:49.5昨收:48.97
最高:49.77 最低:49.42
涨停价:0.0跌停价:0.0
总市值:1.128196575E10

快而精医药的热门评论

chuminhua2020-11-15 22:55

11/11,Qiagen已开始与一家专注于细胞疗法的生物技术初创公司TScan Therapeutics合作,开发能够全面分析人对该疾病的免疫反应的COVID-19诊断测试。总部位于波士顿地区的TScan Therapeutics于2019年7月成立,目标是确定血液癌症和实体瘤中T细胞疗法的新靶标。TScan 将获得所发现的T细胞靶标的选择权...查看全文

快而精医药(QGEN)2020-11-13 05:36

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000064 Act: 34 Size: 48 KB 网页链接查看全文

快而精医药(QGEN)2020-11-02 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000061 Act: 34 Size: 1 MB 网页链接查看全文

快而精医药(QGEN)2020-10-28 03:36

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000058 Act: 34 Size: 641 KB 网页链接查看全文

快而精医药(QGEN)2020-10-14 00:18

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000055 Act: 34 Size: 56 KB 网页链接查看全文

快而精医药(QGEN)2019-07-21 07:36

$快而精医药(QGEN)$ 美东时间 2019-07-30 盘后 披露财报,预期EPS 0.34 网页链接查看全文

快而精医药(QGEN)2019-08-01 18:20

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-01 AccNo: 0001015820-19-000027 Size: 1 MB 网页链接查看全文

快而精医药(QGEN)2019-08-01 18:20

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-01 AccNo: 0001015820-19-000025 Size: 105 MB 网页链接查看全文

快而精医药(QGEN)2020-08-22 01:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000052 Act: 34 Size: 63 KB 网页链接查看全文

快而精医药(QGEN)2019-08-01 18:20

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-01 AccNo: 0001015820-19-000026 Size: 609 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

专项披露公告

快而精医药(QGEN)06-01 18:06

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

快而精医药(QGEN)04-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)04-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接查看全文

定期披露文件

快而精医药(QGEN)03-14 19:36

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接查看全文

年度财报

快而精医药(QGEN)03-14 19:27

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30